According to AN2 Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.80. In 2022 the company made an earnings per share (EPS) of -$4.70 a decrease over its 2021 EPS that were of -$1.85.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.80 | -40.45% |
2022 | -$4.70 | 154.79% |
2021 | -$1.85 |